Samuel Costello

Samuel Costello

Adelaide Medical School

Faculty of Health and Medical Sciences

Eligible to supervise Masters and PhD (as Co-Supervisor) - email supervisor to discuss availability.


Dr Samuel Costello - MBBS FRACP PhD - TITLEHOLDER.
Gastroenterologist
Dr Costello graduated from medical school at the University of Adelaide in 2004 and then completed basic physician training at the Royal Adelaide Hospital followed by Gastroenterology training at The Queen Elizabeth Hospital and Repatriation general hospital. He undertook a clinical fellowship in inflammatory bowel disease at St Mark’s hospital in London in 2016.

Dr Costello is a staff specialist at The Queen Elizabeth Hospital and a consultant with the inflammatory bowel disease service. He is the co-lead of IBD research at The Queen Elizabeth Hospital. Dr Costello established and continues to manage the South Australian faecal microbiota transplantation (FMT) service for the treatment of Clostridium difficile infection and has advised other groups in Australia and internationally about developing similar services.

Dr Costello is passionate about medical research. He completed a PhD at the University of Adelaide where the focus of his research was FMT as a treatment for ulcerative colitis. He has published multiple papers in peer-reviewed international journals and has been an invited speaker at national and international conferences on the topics of FMT and microbial therapeutics.

Dr Costello co-founded microbial therapeutics company BiomeBank in 2018, that supplies donor derived FMT product to Australian hospitals and is developing second generation defined microbial therapies. Dr Costello is Chief Medical Officer and a Director of BiomeBank.

Sam enjoys teaching both medical students as well as doctors in training and is a clinical lecturer at the University of Adelaide.

  • Appointments

    Date Position Institution name
    2020 - ongoing Chief Medial Officer Biomebank
    2019 - 2020 CEO BiomeBank
    2015 - ongoing Clnical Lecturer University of Adelaide
    2013 - ongoing Gastroenterologist The Queen Elizabeth Hospital
  • Education

    Date Institution name Country Title
    University of Adelaide Australia MBBS
    University of Adelaide Australia PhD
  • Postgraduate Training

    Date Title Institution Country
    Gastroenterology Royal Australasian College of Physicians Australia
  • Journals

    Year Citation
    2024 Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2024). Author reply to Hettiarachchi et al. (re Helicobacter pylori resistance in Australia…). Internal Medicine Journal, 54(2), 356-357.
    DOI
    2023 Bosnjak, M., Karpe, A. V., Van, T. T. H., Kotsanas, D., Jenkin, G. A., Costello, S. P., . . . Lyras, D. (2023). Multi-omics analysis of hospital-acquired diarrhoeal patients reveals biomarkers of enterococcal proliferation and Clostridioides difficile infection. Nature Communications, 14(1), 7737.
    DOI
    2023 Li, A., Bowen, J. M., Ball, I. A., Wilson, S., Yong, A., Yeung, D. T., . . . Wardill, H. R. (2023). Autologous Faecal Microbiota Transplantation to Improve Outcomes of Haematopoietic Stem Cell Transplantation: Results of a Single-Centre Feasibility Study. Biomedicines, 11(12), 1-9.
    DOI
    2023 Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2023). Cover Image. Alimentary Pharmacology & Therapeutics, 57(1).
    DOI
    2023 Raja, S. S., Bryant, R. V., Costello, S. P., Barnett, M., Schubert, J., & Rayner, C. K. (2023). Systematic review of therapies for refractory ulcerative proctitis. Journal of Gastroenterology and Hepatology (Australia), 38(4), 496-509.
    DOI Scopus2 WoS2
    2023 Castle, J. W., Butzbach, D. M., Walker, G. S., Lenehan, C. E., Reith, F., Costello, S. P., & Kirkbride, K. P. (2023). Microbial degradation products of lurasidone and their significance in postmortem toxicology. Drug Testing and Analysis, 15(5), 551-565.
    DOI
    2023 Tucker, E. C., Haylock-Jacobs, S., Rapaic, M., Dann, L. M., Bryant, R. V., & Costello, S. P. (2023). Stool donor screening within a Therapeutic Goods Administration compliant donor screening program for fecal microbiota transplantation. JGH Open, 7(3), 172-177.
    DOI Scopus2 WoS2 Europe PMC2
    2023 Lopetuso, L. R., Deleu, S., Godny, L., Petito, V., Puca, P., Facciotti, F., . . . Scaldaferri, F. (2023). The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease. Gut, 72(9), 1642-1650.
    DOI Scopus6 WoS4 Europe PMC3
    2023 Schubert, J. P., Ingram, P. R., Warner, M. S., Rayner, C. K., Roberts-Thomson, I. C., Costello, S. P., & Bryant, R. V. (2023). Refractory Helicobacter pylori infection in Australia: updated multicentre antimicrobial resistance. Internal Medicine Journal, 53(11), 1972-1978.
    DOI Scopus2
    2023 Castle, J. W., Butzbach, D. M., Walker, G. S., Lenehan, C. E., Reith, F., Costello, S. P., & Kirkbride, K. P. (2023). In vitro degradation of ziprasidone in human whole blood. Drug Testing and Analysis, 15(2), 220-234.
    DOI
    2023 Bogatic, D., Bryant, R. V., Lynch, K. D., & Costello, S. P. (2023). Systematic review: microbial manipulation as therapy for primary sclerosing cholangitis. Alimentary Pharmacology and Therapeutics, 57(1), 23-36.
    DOI Scopus1 Europe PMC2
    2022 Schubert, J. P., Rayner, C. K., Costello, S. P., Roberts-Thomson, I. C., Forster, S. C., & Bryant, R. V. (2022). Helicobacter pylori: Have potential benefits been overlooked?. JGH Open, 6(11), 735-737.
    DOI Scopus3 WoS1 Europe PMC2
    2022 Castle, J. W., Butzbach, D. M., Reith, F., Walker, G. S., Lenehan, C. E., Costello, S. P., & Kirkbride, K. P. (2022). Investigations into the stability of 17 psychoactive drugs in a “simulated postmortem blood” model. Drug Testing and Analysis, 14(7), 1200-1222.
    DOI Scopus2 WoS2
    2022 Wardill, H. R., Chan, R. J., Chan, A., Keefe, D., Costello, S. P., & Hart, N. H. (2022). Dual contribution of the gut microbiome to immunotherapy efficacy and toxicity: supportive care implications and recommendations.. Support Care Cancer, 30(8), 6369-6373.
    DOI Scopus7 WoS6 Europe PMC6
    2022 Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Warner, M. S., Roberts-Thomson, I. C., . . . Bryant, R. V. (2022). Geospatial analysis of Helicobacter pylori infection in South Australia: should location influence eradication therapy?. Journal of gastroenterology and hepatology, 37(7), 1263-1274.
    DOI Scopus6 WoS4 Europe PMC4
    2022 Day, A. S., Yao, C. K., Costello, S. P., Ruszkiewicz, A., Andrews, J. M., Gibson, P. R., & Bryant, R. V. (2022). Therapeutic Potential of the 4 Strategies to SUlfide-REduction (4-SURE) Diet in Adults with Mild to Moderately Active Ulcerative Colitis: An Open-Label Feasibility Study. Journal of Nutrition, 152(7), 1690-1701.
    DOI Scopus10 WoS8 Europe PMC7
    2022 Gulliver, E. L., Young, R. B., Chonwerawong, M., D'Adamo, G. L., Thomason, T., Widdop, J. T., . . . Forster, S. C. (2022). Review article: the future of microbiome-based therapeutics. Alimentary Pharmacology and Therapeutics, 56(2), 192-208.
    DOI Scopus17 WoS7 Europe PMC8
    2022 Soo, W. T., Costello, S. P., & Bryant, R. V. (2022). Dialing Back M for Monoclonal: Successful De-escalation of Dose-Intensified Anti-tumor Necrosis Factor Therapy in Inflammatory Bowel Disease. Digestive Diseases and Sciences, 67(1), 8-10.
    DOI
    2022 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2022). Food-related quality of life in adults with inflammatory bowel disease is associated with restrictive eating behaviour, disease activity and surgery: A prospective multicentre observational study. Journal of Human Nutrition and Dietetics, 35(1), 234-244.
    DOI Scopus14 WoS13 Europe PMC9
    2022 Santos-Paulo, S., Costello, S. P., Forster, S. C., Travis, S. P., & Bryant, R. V. (2022). The gut microbiota as a therapeutic target for obesity: A scoping review. Nutrition Research Reviews, 35(2), 207-220.
    DOI Scopus13 WoS11 Europe PMC7
    2021 Bryant, R. V., Day, A. S., McGrath, K. C., Telfer, K., Yao, C. K., & Costello, S. P. (2021). Fecal microbiota transplantation augmented by a sulfide-reducing diet for refractory ulcerative colitis: A case report with functional metagenomic analysis. JGH Open, 5(9), 1099-1102.
    DOI Scopus5 WoS5 Europe PMC3
    2021 Day, A. S., Yao, C. K., Costello, S. P., Andrews, J. M., & Bryant, R. V. (2021). Food avoidance, restrictive eating behaviour and association with quality of life in adults with inflammatory bowel disease: A systematic scoping review. Appetite, 167, 16 pages.
    DOI Scopus20 WoS15 Europe PMC13
    2021 Goodsall, T. M., Noy, R., Nguyen, T. M., Costello, S. P., Jairath, V., & Bryant, R. V. (2021). Systematic Review: Patient Perceptions of Monitoring Tools in Inflammatory Bowel Disease.. Journal of the Canadian Association of Gastroenterology, 4(2), e31-e41.
    DOI Europe PMC14
    2021 Davis, R., Day, A., Barrett, J., Vanlint, A., Andrews, J. M., Costello, S. P., & Bryant, R. V. (2021). Habitual dietary fibre and prebiotic intake is inadequate in patients with inflammatory bowel disease: findings from a multicentre cross-sectional study.. Journal of Human Nutrition and Dietetics, 34(2), 420-428.
    DOI Scopus13 WoS12 Europe PMC9
    2021 Schubert, J. P., Warner, M. S., Rayner, C. K., Roberts-Thomson, I., Mangoni, A. A., Costello, S., & Bryant, R. V. (2021). Increasing Helicobacter pylori clarithromycin resistance in Australia over 20 years. Internal Medicine Journal, 52(9), 1554-1560.
    DOI Scopus9 WoS6 Europe PMC6
    2021 Schubert, J. P., Gehlert, J., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., Mangoni, A. A., & Bryant, R. V. (2021). Antibiotic Resistance of Helicobacter pylori in Australia and New Zealand: A Systematic Review and Meta-analysis. Journal of gastroenterology and hepatology, 36(6), 1450-1456.
    DOI Scopus10 WoS10 Europe PMC8
    2021 Day, A. S., Davis, R., Costello, S. P., Yao, C. K., Andrews, J. M., & Bryant, R. V. (2021). The Adequacy of Habitual Dietary Fiber Intake in Individuals With Inflammatory Bowel Disease: A Systematic Review. Journal of the Academy of Nutrition and Dietetics, 121(4), 688-708.e3.
    DOI Scopus14 WoS11 Europe PMC5
    2021 Ianiro, G., Mullish, B. H., Hvas, C. L., Segal, J. P., Kuijper, E. J., Costello, S. P., . . . Cammarota, G. (2021). SARS-CoV-2 vaccines and donor recruitment for FMT. The Lancet Gastroenterology and Hepatology, 6(4), 264-266.
    DOI Scopus7 WoS5 Europe PMC3
    2021 Deputy, M., Segal, J., Reza, L., Worley, G., Costello, S., Burns, E., . . . Hart, A. (2021). The pouch behaving badly: management of morbidity after ileal pouch–anal anastomosis. Colorectal Disease, 23(5), 1193-1204.
    DOI Scopus4 WoS5 Europe PMC1
    2020 Chande, N., Costello, S. P., Limketkai, B. N., Parker, C. E., Nguyen, T. M., MacDonald, J. K., & Feagan, B. G. (2020). Alternative and complementary approaches for the treatment of inflammatory bowel disease: Evidence from cochrane reviews. Inflammatory Bowel Diseases, 26(6), 843-851.
    DOI Scopus7 Europe PMC6
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Histological Healing in Ulcerative Colitis: Near Enough Is Not Good Enough. Journal of Crohn's and Colitis, 14(10), 1341-1342.
    DOI Scopus1 WoS1 Europe PMC1
    2020 Aysha, A. -A., Rentsch, C., Prentice, R., Johnson, D., Bryant, R. V., Ward, M. G., . . . Christensen, B. (2020). Practical management of inflammatory bowel disease patients during the COVID-19 pandemic: expert commentary from the Gastroenterological Society of Australia Inflammatory Bowel Disease faculty.. Intern Med J, 50(7), 798-804.
    DOI Scopus10 WoS10 Europe PMC10
    2020 Ianiro, G., Mullish, B. H., Kelly, C. R., Kassam, Z., Kuijper, E. J., Ng, S. C., . . . Cammarota, G. (2020). Reorganisation of faecal microbiota transplant services during the COVID-19 pandemic.. Gut, 69(9), 1555-1563.
    DOI Scopus108 WoS82 Europe PMC66
    2020 Vanlint, A. S., Kaazan, P., Kwok, M., Bryant, R. V., Ooi, M., Bak, N., & Costello, S. (2020). Lessons from practice Low attenuation lymphadenopathy on computed tomography leading to diagnosis of Whipple disease. Medical Journal of Australia, 213(4), 161-162.e1.
    DOI
    2020 Gill, M., Blacketer, C., Chitti, F., Telfer, K., Papanicolas, L., Dann, L. M., . . . Costello, S. P. (2020). Physician and patient perceptions of fecal microbiota transplant for recurrent or refractory Clostridioides difficile in the first 6 years of a central stool bank. JGH Open, 4(5), 950-957.
    DOI Scopus8 WoS7 Europe PMC4
    2020 Costello, S. P., Day, A., Yao, C. K., & Bryant, R. V. (2020). Faecal microbiota transplantation (FMT) with dietary therapy for acute severe ulcerative colitis.. BMJ Case Rep, 13(8), 3 pages.
    DOI Scopus12 WoS9 Europe PMC7
    2020 Lett, B., Costello, S., & Roberts-Thomson, I. (2020). Analyzing the intestinal microbiome in inflammatory bowel disease: From RNA to multiomics. JGH Open, 4(5), 779-781.
    DOI
    2020 Noble, A., Durant, L., Hoyles, L., McCartney, A. L., Man, R., Segal, J., . . . Knight, S. C. (2020). Deficient Resident Memory T Cell and CD8 T Cell Response to Commensals in Inflammatory Bowel Disease. Journal of Crohn's and Colitis, 14(4), 525-537.
    DOI Scopus38 WoS36 Europe PMC30
    2020 Rajagopalan, A., Sathananthan, D., An, Y. K., Van De Ven, L., Martin, S., Fon, J., . . . Bryant, R. V. (2020). Gastrointestinal ultrasound in inflammatory bowel disease care: Patient perceptions and impact on disease-related knowledge. JGH Open, 4(2), 267-272.
    DOI Scopus31 WoS20 Europe PMC17
    2020 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Martin, S., Fon, J., Costello, S., & Bryant, R. V. (2020). Point-of-care gastrointestinal ultrasound in inflammatory bowel disease: An accurate alternative for disease monitoring. JGH Open, 4(2), 273-279.
    DOI Scopus11 WoS10 Europe PMC6
    2020 Costello, S. P., & Bryant, R. V. (2020). Editorial: faecal microbiota transplantation—the silver bullet for severe and fulminant Clostridioides difficile infection?. Alimentary Pharmacology and Therapeutics, 51(1), 180-181.
    DOI
    2020 Haifer, C., Kelly, C. R., Paramsothy, S., Andresen, D., Papanicolas, L. E., McKew, G. L., . . . Leong, R. W. (2020). Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.. Gut, 69(5), 801-810.
    DOI Scopus50 WoS46 Europe PMC32
    2020 Ianiro, G., Mullish, B., Kelly, C., Sokol, H., Kassam, Z., Ng, S., . . . Cammarota, G. (2020). Screening of faecal microbiota transplant donors during the COVID-19 outbreak: suggestions for urgent updates from an international expert panel. The Lancet Gastroenterology and Hepatology, 5(5), 430-432.
    DOI Scopus101 WoS88 Europe PMC80
    2020 Soo, W. T., Bryant, R. V., & Costello, S. P. (2020). Faecal microbiota transplantation: Indications, evidence and safety. Australian Prescriber, 43(2), 36-38.
    DOI Scopus1 WoS1
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). Coronavirus disease 2019 (COVID-19) and implications for thiopurine use.. Med J Aust, 212(10), 490-490.e1.
    DOI Scopus4 WoS4 Europe PMC4
    2020 Goodsall, T. M., Costello, S. P., & Bryant, R. V. (2020). ABC of topical therapy in inflammatory bowel disease. JGH Open, 4(4), 556-557.
    DOI Scopus2 WoS2 Europe PMC2
    2019 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2019). Visceral Adipose Tissue Is Associated With Stricturing Crohn's Disease Behavior, Fecal Calprotectin, and Quality of Life. Inflammatory bowel diseases, 25(3), 592-600.
    DOI Scopus43 WoS38 Europe PMC28
    2019 Bryant, R. V., Schultz, C. G., Ooi, S., Goess, C., Costello, S. P., Vincent, A. D., . . . Andrews, J. M. (2019). Authors' reply: The Association Between Visceral Adipose Tissue and Stricturing Crohn's Disease Behavior, Fecal Calprotectin and Quality of Life. Inflammatory bowel diseases, 25(6), e62-e63.
    DOI
    2019 Costello, S. P., Hughes, P. A., Waters, O., Bryant, R. V., Vincent, A. D., Blatchford, P., . . . Andrews, J. M. (2019). Effect of fecal microbiota transplantation on 8-week remission in patients with ulcerative colitis: a randomized clinical trial. JAMA - Journal of the American Medical Association, 321(2), 156-164.
    DOI Scopus500 WoS440 Europe PMC270
    2019 Costello, S., & Bryant, R. (2019). Faecal microbiota transplantation in Australia: bogged down in regulatory uncertainty. Internal Medicine Journal, 49(2), 148-151.
    DOI Scopus9 WoS7 Europe PMC5
    2019 Papanicolas, L. E., Choo, J. M., Wang, Y., Leong, L. E. X., Costello, S. P., Gordon, D. L., . . . Rogers, G. B. (2019). Bacterial viability in faecal transplants: Which bacteria survive?. EBioMedicine, 41, 509-516.
    DOI Scopus80 WoS68 Europe PMC56
    2019 Wardill, H., Secombe, K., Bryant, R., Hazenberg, M. D., & Costello, S. (2019). Adjunctive fecal microbiota transplantation in supportive oncology: emerging indications and considerations in immunocompromised patients. EBioMedicine, 44, 730-740.
    DOI Scopus43 WoS36 Europe PMC27
    2019 Selvanderan, S. P., Goldblatt, F., Nguyen, N. Q., & Costello, S. P. (2019). Faecal microbiota transplantation for Clostridium difficile infection resulting in a decrease in psoriatic arthritis disease activity. Clinical and experimental rheumatology, 37(3), 514-515.
    Scopus17 WoS15 Europe PMC11
    2019 Bryant, R. V., & Costello, S. P. (2019). Editorial: assessing histological disease activity in Crohn’s disease—a call for standardisation of mucosal biopsy location. Alimentary Pharmacology and Therapeutics, 50(1), 103-104.
    DOI Scopus2 WoS2 Europe PMC1
    2019 Costello, S. P., Conlon, M. A., & Andrews, J. M. (2019). Fecal microbiota transplantation for ulcerative colitis-Reply. JAMA - Journal of the American Medical Association, 321(22), 2240-2241.
    DOI Scopus5 WoS5 Europe PMC4
    2019 Cammarota, G., Ianiro, G., Kelly, C. R., Mullish, B. H., Allegretti, J. R., Kassam, Z., . . . Gasbarrini, A. (2019). International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.. Gut, 68(12), 2111-2121.
    DOI Scopus267 WoS219 Europe PMC153
    2019 Kuijper, E. J., Allegretii, J., Hawkey, P., Sokol, H., Goldenberg, S., Ianiro, G., . . . Vehreschild, M. J. G. T. (2019). A necessary discussion after transmission of multidrug-resistant organisms through faecal microbiota transplantations. The Lancet Infectious Diseases, 19(11), 1161-1162.
    DOI Scopus7 WoS7 Europe PMC4
    2019 Roberts-Thomson, I. C., Bryant, R. V., & Costello, S. P. (2019). Uncovering the cause of ulcerative colitis.. JGH open : an open access journal of gastroenterology and hepatology, 3(4), 274-276.
    DOI Scopus11 WoS10 Europe PMC4
    2018 Bryant, R., Schultz, C., Ooi, S., Goess, C., Costello, S., Vincent, A., . . . Andrews, J. (2018). Obesity in inflammatory bowel disease: gains in adiposity despite high prevalence of Myopenia and Osteopenia. Nutrients, 10(9), 1192-1-1192-17.
    DOI Scopus51 WoS44 Europe PMC26
    2018 Bryant, R., Costello, S., Schoeman, S., Sathananthan, D., Knight, E., Lau, S. -Y., . . . Andrews, J. (2018). Limited uptake of ulcerative colitis 'treat to target' recommendations in real-world practice. Journal of gastroenterology and hepatology, 33(3), 599-607.
    DOI Scopus33 WoS26 Europe PMC17
    2017 Costello, S. P., Soo, W., Bryant, R. V., Jairath, V., Hart, A. L., & Andrews, J. M. (2017). Editorial: faecal microbiota transplantation for ulcerative colitis—not quite there yet? Authors’ reply. Alimentary Pharmacology and Therapeutics, 46(6), 631-632.
    DOI
    2017 Costello, S., Soo, W., Bryant, R., Jairath, V., Hart, A., & Andrews, J. (2017). Systematic review with meta-analysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Alimentary Pharmacology and Therapeutics, 46(3), 213-224.
    DOI Scopus198 WoS175 Europe PMC131
    2016 Costello, S., Tucker, E., La Brooy, J., Schoeman, M., & Andrews, J. (2016). Establishing a fecal microbiota transplant service for the treatment of Clostridium difficile infection. Clinical Infectious Diseases, 62(7), 908-914.
    DOI Scopus82 WoS78 Europe PMC51
    2016 Hughes, P., Costello, S., Bryant, R., & Andrews, J. (2016). Opioidergic effects on enteric and sensory nerves in the lower GI tract: basic mechanisms and clinical implications. American Journal of Physiology, 311(3), G501-G513.
    DOI Scopus20 WoS15 Europe PMC12
    2016 Andrews, J. M., Costello, S. P., Agarwal, A. K., Bampton, P., Beswick, L., Connor, S., . . . Walsh, A. J. (2016). Conflict of interest: Real and perceived - a more mature consideration is needed. Internal Medicine Journal, 46(3), 377-379.
    DOI
    2015 Costello, S. P., Chung, A., Andrews, J. M., & Fraser, R. J. (2015). Fecal microbiota transplant for Clostridium difficile colitis-induced toxic megacolon. American Journal of Gastroenterology, 110(5), 775-777.
    DOI Scopus22 WoS22 Europe PMC13
    2015 Costello, S., Ghaly, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Compassionate access anti-tumour necrosis factor-α therapy for ulcerative colitis in Australia: the benefits to patients. Internal Medicine Journal, 45(6), 659-666.
    DOI Scopus4 WoS3 Europe PMC3
    2015 Costello, S., Conlon, M., Vuaran, M., Roberts-Thomson, I., & Andrews, J. (2015). Faecal microbiota transplant for recurrent Clostridium difficile infection using long-term frozen stool is effective: Clinical efficacy and bacterial viability data. Alimentary Pharmacology and Therapeutics, 42(8), 1011-1018.
    DOI Scopus99 WoS88 Europe PMC67
    2015 Ghaly, S., Costello, S., Beswick, L., Pudipeddi, A., Agarwal, A., Sechi, A., . . . Andrews, J. (2015). Dose tailoring of anti-tumour necrosis factor-alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Internal Medicine Journal, 45(2), 170-177.
    DOI Scopus6 WoS6 Europe PMC4
    2015 Bryant, R. V., Costello, S. P., & Andrews, J. M. (2015). Editorial: Untangling symptoms from mucosal healing in UC - A note of caution for patient-reported outcomes. Alimentary Pharmacology and Therapeutics, 42(11-12), 1327-1328.
    DOI Scopus1 WoS1 Europe PMC1
    2014 Andrews, J., & Costello, S. (2014). The emerging role of faecal microbiota transplantation. Medicine Today, 15(7), 62-64.
    Scopus1
    2011 Costello, S., & Singh, R. (2011). Endoscopic imaging in Barrett's oesophagus: Applications in routine clinical practice and future outlook. Clinical Endoscopy, 44(2), 87-92.
    DOI Scopus5 WoS4 Europe PMC3
    2004 Teague, B., Morrison, C., Court, F., Chin, V., Costello, S., Kirkwood, I., & Maddern, G. (2004). Role of FDG-PET in surgical management of patients with colorectal liver metastases. Australian and New Zealand Journal of Surgery, 74(8), 646-652.
    DOI Scopus12 WoS8 Europe PMC6
  • Conference Papers

    Year Citation
    2022 Tucker, E., Haylock-Jacobs, S., Bryant, R. V., & Costello, S. (2022). Stool donor screening eligibility and retention with a Therapeutic Goods Order 105-compliant stool donor screening program for fecal microbiota transplantation. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 37 (pp. 208). WILEY.
    2021 Schubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Roberts-Thomson, I. C., Costello, S., & Bryant, R. V. (2021). Geospatial analysis of Helicobacter pylori infection in the Greater Adelaide region over 20 years: Should location influence choice of eradication therapy?. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 36 (pp. 137-138). Virtual online: WILEY.
    2017 Noble, A., Durant, L., Hoyles, L., McCartney, A. L., Man, R., Costello, S. P., . . . Knight, S. C. (2017). Dysregulation of cellular vs humoral immunity to the intestinal microbiota in inflammatory bowel disease. In JOURNAL OF CROHNS & COLITIS Vol. 11 (pp. S123-S124). OXFORD UNIV PRESS.
    2017 Costello, S. P., Van der Poorten, D., & Andrews, J. M. (2017). Fecal microbiota transplantation for recurrent <i>Clostridium difficile</i> infection: When regulatory affairs do not keep pace with evidence-based medicine. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 32 (pp. 156-157). WILEY.
    2012 Agarwal, A., & Costello, S. P. (2012). Compassionate access (CA) use of anti-TNF therapy in inflammatory bowel disease (IBD) patients in Australia: an observational study. In JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY Vol. 27 (pp. 96). WILEY-BLACKWELL.
    2012 Costello, S. P., & Martin, J. (2012). Angioectasia in the Elderly is the Commonest Cause of Obscure Gastrointestinal Bleeding on Capsule Endoscopy. In GASTROINTESTINAL ENDOSCOPY Vol. 75 (pp. 260). San Diego, CA: MOSBY-ELSEVIER.
    WoS2
  • Conference Items

    Year Citation
    2018 Rajagopalan, A., Sathananthan, D., Van De Ven, L., Martin, S., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Acceptability, tolerability, and impact on illness-related knowledge. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2018 Sathananthan, D., Rajagopalan, A., Van De Ven, L., Fon, J., Costello, S. P., & Bryant, R. V. (2018). Gastrointestinal ultrasound in routine inflammatory bowel disease care: Accuracy compared with colonoscopy and fecal calprotectin. Poster session presented at the meeting of JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY. WILEY.
    2018 Hughes, P., Wardill, H., Dmochowska, N., Mavrangelos, C., Campaniello, M., Bowen, J., . . . Andrews, J. (2018). Proteolytic activation of IL-1 beta impairs epithelial barrier integrity in the ulcerative colitis lumen. Poster session presented at the meeting of Journal of Gastroenterology and Hepatology. Brisbane, Qld: Wiley.
    2017 Costello, S. P., Waters, O., Bryant, R. V., Katsikeros, R., Makanyanga, J., Schoeman, M., . . . Andrews, J. M. (2017). SHORT DURATION, LOW INTENSITY, POOLED FECAL MICROBIOTA TRANSPLANTATION INDUCES REMISSION IN PATIENTS WITH MILD-MODERATELY ACTIVE ULCERATIVE COLITIS: A RANDOMISED CONTROLLED TRIAL. Poster session presented at the meeting of GASTROENTEROLOGY. Chicago, IL: W B SAUNDERS CO-ELSEVIER INC.
    DOI WoS37
    2017 Wardill, H., Dmochowska, N., Campaniello, M., Mavrangelos, C., Bowen, J., Andrews, J., . . . Hughes, P. (2017). Fecal supernatants from active ulcerative colitis patients impair colonic epithelial barrier integrity and activate pelvic mucosal extrinsic afferent nerves. Poster session presented at the meeting of FASEB Journal. Chicago, IL: Federation of American Societies for Experimental Biology.
  • Current Higher Degree by Research Supervision (University of Adelaide)

    Date Role Research Topic Program Degree Type Student Load Student Name
    2023 Co-Supervisor The influence of the gastrointestinal microbiome on the development and severity of ulcerative colitis Master of Philosophy (Public Health) Master Part Time Dr Karmen Diane Telfer
    2023 Co-Supervisor Faecal Microbiota Transplant (FMT) as a safe and efficacious therapeutic alternative for refractory proctitis Doctor of Philosophy Doctorate Full Time Dr Sreecanth Raja
    2022 Co-Supervisor Exploring the use of exclusive enteral nutrition in adult patients with Crohn’s disease Master of Philosophy (Medical Science) Master Full Time Dr Matthew Chu

Connect With Me
External Profiles

Other Links